Lapatinib for Brain Metastases In ErbB2-Positive Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

242

Participants

Timeline

Start Date

December 2, 2005

Primary Completion Date

September 25, 2007

Study Completion Date

March 15, 2018

Conditions
Neoplasms, Breast
Interventions
DRUG

lapatinib

tyrosine kinase inhibitor

Trial Locations (74)

114

Novartis Investigative Site, Taipei

736

Novartis Investigative Site, Tainan County

1000

Novartis Investigative Site, Brussels

1211

Novartis Investigative Site, Geneva

2060

Novartis Investigative Site, North Sydney

3128

Novartis Investigative Site, Box Hill

3135

Novartis Investigative Site, Ringwood East

4029

Novartis Investigative Site, Herston

4101

Novartis Investigative Site, South Brisbane

5000

Novartis Investigative Site, Adelaide

6000

Novartis Investigative Site, Perth

6600

Novartis Investigative Site, Locarno

10016

Novartis Investigative Site, Taipei

10021

Novartis Investigative Site, New York

15213

Novartis Investigative Site, Pittsburgh

18547

Novartis Investigative Site, Neo Faliro

19104

Novartis Investigative Site, Philadelphia

20007

Novartis Investigative Site, Washington D.C.

20141

Novartis Investigative Site, Milan

21079

Novartis Investigative Site, Dijon

27599

Novartis Investigative Site, Chapel Hill

28041

Novartis Investigative Site, Madrid

31052

Novartis Investigative Site, Toulouse

32224

Novartis Investigative Site, Jacksonville

33428

Novartis Investigative Site, Boca Raton

37203

Novartis Investigative Site, Nashville

42100

Novartis Investigative Site, Reggio Emilia

46202

Novartis Investigative Site, Indianapolis

46227

Novartis Investigative Site, Indianapolis

48109

Novartis Investigative Site, Ann Arbor

55455

Novartis Investigative Site, Minneapolis

60590

Novartis Investigative Site, Frankfurt am Main

66160

Novartis Investigative Site, Kansas City

75010

Novartis Investigative Site, Paris

75246

Novartis Investigative Site, Dallas

75248

Novartis Investigative Site, Paris

75702

Novartis Investigative Site, Tyler

77030

Novartis Investigative Site, Houston

80220

Novartis Investigative Site, Denver

80637

Novartis Investigative Site, Munich

81377

Novartis Investigative Site, Munich

87106

Novartis Investigative Site, Albuquerque

87108

Novartis Investigative Site, Albuquerque

87505

Novartis Investigative Site, Santa Fe

94115

Novartis Investigative Site, San Francisco

94589

Novartis Investigative Site, Vallejo

98109

Novartis Investigative Site, Seattle

98902

Novartis Investigative Site, Yakima

400026

Novartis Investigative Site, Mumbai

560078

Novartis Investigative Site, Bangalore

51101-1733

Novartis Investigative Site, Sioux City

02115

Novartis Investigative Site, Boston

63110-1093

Novartis Investigative Site, St Louis

87131-0001

Novartis Investigative Site, Albuquerque

A-5020

Novartis Investigative Site, Salzburg

A-1090

Novartis Investigative Site, Vienna

V5Z 4E6

Novartis Investigative Site, Vancouver

K1H 8L6

Novartis Investigative Site, Ottawa

M5B 1W8

Novartis Investigative Site, Toronto

M5G 2M9

Novartis Investigative Site, Toronto

M9N 1N8

Novartis Investigative Site, Weston

06156

Novartis Investigative Site, Perugia

464-8681

Novartis Investigative Site, Aichi

350-0495

Novartis Investigative Site, Saitama

350-1298

Novartis Investigative Site, Saitama

104-0045

Novartis Investigative Site, Tokyo

113-8677

Novartis Investigative Site, Tokyo

135-8550

Novartis Investigative Site, Tokyo

10-228

Novartis Investigative Site, Olsztyn

02-781

Novartis Investigative Site, Warsaw

08035

Novartis Investigative Site, Barcelona

SE-751 85

Novartis Investigative Site, Uppsala

M20 4BX

Novartis Investigative Site, Manchester

BN2 5BE

Novartis Investigative Site, Brighton

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY